Autori: Andric Zoran G
Naslov | Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article) |
Autori | Syrigos Konstantinos Abert Istvan Andric Zoran G ![]() |
Info | BIODRUGS, (2021), vol. 35 br. 4, str. 417-428 |
Projekat | Centus Biotherapeutics |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction (Meeting Abstract) |
Autori | Maglakelidze Marina ... Andric Zoran G ![]() ![]() |
Info | ANNALS OF ONCOLOGY, (2021), vol. 32 br. , Suppl. 3, str. S154-S154 |
Projekat | Imugene Limited |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA) (Article) |
Autori | Trukhin Dmytro ... Andric Zoran G ![]() |
Info | BIODRUGS, (2021), vol. 35 br. 4, str. 429-444 |
Projekat | mAbxience Research SL |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC) (Meeting Abstract) |
Autori | Andric Zoran G ![]() ![]() |
Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 4, Suppl. S, str. S753-S754 |
Projekat | Merck KGaA, Darmstadt, Germany; Merck KGaA; Pfizer |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1-Selected NSCLC (Meeting Abstract) |
Autori | Herbst Roy S ... Andric Zoran G ![]() |
Info | JOURNAL OF THORACIC ONCOLOGY, (2021), vol. 16 br. 3, Suppl. S, str. S224-S225 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study (Article) |
Autori | Hart Lowell L Ferrarotto Renata Andric Zoran G ![]() ![]() |
Info | ADVANCES IN THERAPY, (2021), vol. 38 br. 1, str. 350-365 |
Projekat | G1 Therapeutics, Inc. (Research Triangle Park, NC) |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 (Meeting Abstract) |
Autori | Herbst Roy S ... Andric Zoran G ![]() |
Info | SWISS MEDICAL WEEKLY, (2020), vol. br. , Suppl. 247, str. 31S-32S |
Projekat | F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924 (Meeting Abstract) |
Autori | Andric Zoran G ![]() ![]() ![]() ![]() |
Info | EUROPEAN JOURNAL OF CANCER, (2020), vol. 138 br. , Suppl. 2, str. S5-S5 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Assessment of age-related influences on the quality of life of breast cancer patients before and after surgical treatment (Article) |
Autori | Kostic Sanja V Murtezani Zafir Andric Zoran G ![]() ![]() ![]() ![]() |
Info | VOJNOSANITETSKI PREGLED, (2020), vol. 77 br. 9, str. 908-916 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC (Article) |
Autori | Herbst Roy S ... Andric Zoran G ![]() |
Info | NEW ENGLAND JOURNAL OF MEDICINE, (2020), vol. 383 br. 14, str. 1328-1339 |
Projekat | Roche HoldingGenentech; IMpower110 ClinicalTrials.gov number [NCT02409342] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|